CHARLOTTE, N.C.–()–cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of many nation’s main and most extremely trusted and acknowledged cannabidiol (CBD) manufacturers, confirmed at the moment that it’s on monitor to submit its Novel Foods Dossier with the United Kingdom’s Food Safety Agency (FSA) by the required regulatory submitting deadline of March 31, 2021.

“By allowing CBD product manufacturers to obtain a Novel Food Authorization from the FSA, the UK is now leading the world in CBD regulation. cbdMD believes it’s in a unique position to demonstrate the safety of its products to the FSA and therefore we believe will be one of the few CBD companies that will be allowed to continue to sell their CBD products on UK’s retail store shelves after the March 31, 2021 deadline. We know that major UK retailers have delayed new CBD product introductions until CBD brands are cleared by the FSA. cbdMD believes if it is successful in obtaining FSA approval, it will have a competitive advantage and therefore a significant opportunity for brand expansion in the UK market. We believe that the expected successful completion of this regulatory approval process provides cbdMD a valuable tool as we continue to prepare for other regulatory approvals around the world,” mentioned Chief Marketing Officer, Ken Cohn.

cbdMD is working together with a number one meals security and regulatory advisor within the UK to arrange the file which is able to embody detailed evaluation of the standard and stability of our product, our hemp sourcing and extraction controls, our labelling and testing necessities, and the underlying consumption and toxicological knowledge associated to the protected consumption of the proprietary cannabinoid mix components in our cbdMD product line. cbdMD believes this step is vital as a precursor for its preparation of its EU and FDA NDIN submissions.

About cbdMD, Inc.

cbdMD, Inc. is without doubt one of the main, most extremely trusted, and most acknowledged cannabidiol (CBD) manufacturers, whose present merchandise embody CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bathtub bombs and CBD pet merchandise. cbdMD can also be a proud associate of Bellator MMA and Life Time, Inc., and has one of many largest rosters {of professional} sports activities athletes who’re a part of “Team cbdMD.” To be taught extra about cbdMD and our complete line of over 100 SKUs of U.S. produced, Non-THC1 CBD merchandise, please go to, observe cbdMD on Instagram and Facebook, or go to one of many 6,000 stores that carry cbdMD merchandise.

1 Non-THC is outlined as under the extent of detection utilizing validated scientific analytical instruments.

Forward-Looking Statements

This press launch incorporates sure forward-looking statements which might be based mostly upon present expectations and contain sure dangers and uncertainties inside the which means of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements might be recognized by way of phrases comparable to ”ought to,” ”could,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”initiatives,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements should not ensures of future efficiency and are topic to dangers, uncertainties, and different elements, a few of that are past our management and tough to foretell and will trigger precise outcomes to vary materially from these expressed or forecasted within the forward-looking statements. You are urged to fastidiously assessment and contemplate any cautionary statements and different disclosures, together with the statements made underneath the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-Okay for the fiscal 12 months ended September 30, 2019 and Part II, Item 1A. Risk Factors showing in its Quarterly Report on Form 10-Q for the interval ended June 30, 2020, each as filed with the Securities and Exchange Commission (the “SEC”) and our different filings with the SEC. All forward-looking statements contain vital dangers and uncertainties that would trigger precise outcomes to vary materially from these within the forward-looking statements, lots of that are usually exterior the management of cbdMD, Inc. and are tough to foretell. cbdMD, Inc. doesn’t undertake any responsibility to replace any forward-looking statements besides as could also be required by regulation. The info which seems on our web sites and our social media platforms, together with, however not restricted to, Instagram and Facebook, isn’t a part of this press launch.

Source link